Patents by Inventor John St. Cyr

John St. Cyr has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200206252
    Abstract: D-ribose is administered to patients suffering an acute myocardial infarction during first response care, in order to prevent cardiac compromise. In those patients able to ingest fluids, two to five grams of D-ribose is administered orally. In a patients unable to ingest fluids, or in a patient with and intravenous line, pyrogen-free D-ribose is administered intravenously at a rate of 50-300 mg/kg/hour.
    Type: Application
    Filed: March 8, 2019
    Publication date: July 2, 2020
    Inventors: John A. St. Cyr, David J. Perkowski
  • Publication number: 20190275065
    Abstract: A method for improving ventilatory efficiency, comprising the administration of a pentose is disclosed. The most preferred pentose is D-ribose, to be administered in a dosage of from two to ten grams, one to four times daily for at least a week, but most preferably long term.
    Type: Application
    Filed: May 22, 2019
    Publication date: September 12, 2019
    Inventors: Dean J. MacCarter, John A. St. Cyr
  • Publication number: 20170326165
    Abstract: D-ribose is administered to patients suffering an acute myocardial infarction during first response care, in order to prevent cardiac compromise. In those patients able to ingest fluids, two to five grams of D-ribose is administered orally. In a patients unable to ingest fluids, or in a patient with and intravenous line, pyrogen-free D-ribose is administered intravenously at a rate of 50-300 mg/kg/hour.
    Type: Application
    Filed: April 26, 2017
    Publication date: November 16, 2017
    Inventors: John A. St. Cyr, David J. Perkowski
  • Publication number: 20170157157
    Abstract: A method for improving ventilatory efficiency, comprising the administration of a pentose is disclosed. The most preferred pentose is D-ribose, to be administered in a dosage of from two to ten grams, one to four times daily for at least a week, but most preferably long term.
    Type: Application
    Filed: December 22, 2016
    Publication date: June 8, 2017
    Inventors: Dean J. MACCARTER, John A. ST. CYR
  • Patent number: 9572882
    Abstract: The present invention relates to methods for supplementing the diet of subjects suffering from cardiovascular disease. D-Ribose is given long term alone or in combination with vasodilators in order to improve or maintain the diastolic or systolic function of the subjects.
    Type: Grant
    Filed: June 26, 2009
    Date of Patent: February 21, 2017
    Assignee: RiboCor, INC.
    Inventors: Terri L. Butler, John St. Cyr, Clarence A. Johnson
  • Publication number: 20160317561
    Abstract: Low doses of D-ribose raise the level of fitness and lower the perception of fatigue in baby boomers aged 45-65 who perceive themselves as fatigued. The doses range from 0.100 grams to 3.0 grams, bid, for a total of 0.200 to 6.0 grams daily. Objective measures of cardiopulmonary parameters confirm the improvement of fitness and questionnaires confirm that quality of life and mental states are improved with D-ribose administration.
    Type: Application
    Filed: July 12, 2016
    Publication date: November 3, 2016
    Inventors: John A. St. Cyr, Dean J. MacCarter
  • Publication number: 20160199460
    Abstract: The invention provides a formulation for treating stress and lessening fatigue. The formulation can be combined with water or another suitable liquid to provide a beverage for ease of administration. The formulation can include one or more of an energy compound, a vasodilator, a vasodilator adjuvant, and an antioxidant enhancer. In a typical formulation the energy compound is D-ribose or guanosine. The formulation can improve energy and alertness, and reduce the effects of stress and fatigue.
    Type: Application
    Filed: January 19, 2016
    Publication date: July 14, 2016
    Applicant: HydroPep, LLC
    Inventors: John A. St. Cyr, Dean J. MacCarter
  • Patent number: 8835396
    Abstract: This invention discloses a method and compositions for treatment or prevention of pulmonary hypertension in a mammal. Representative mammals include humans and horses. The invention further relates to supplements especially beneficial in preventing or stopping the progression of pulmonary hypertension. The supplements include ribose and folate. Additional nutrients include omega-3 fatty acids and gamma-linolenic acid.
    Type: Grant
    Filed: December 15, 2006
    Date of Patent: September 16, 2014
    Assignee: Bioenergy, Inc.
    Inventors: George Verlaan, John A. St. Cyr
  • Patent number: 8759315
    Abstract: A ribose-related compound is added to whole blood or packed red cells which have suboptimal function as measured by decreased levels of 2,3-DPG in order to rejuvenate the red blood cells to normal function as seen by raised levels of 2,3-DPG. Two representative ribose-related compounds are D-ribose and inosine.
    Type: Grant
    Filed: January 5, 2007
    Date of Patent: June 24, 2014
    Assignee: Viacell, LLC
    Inventors: John A St. Cyr, Daniel G Ericson, Clarence A Johnson
  • Patent number: 8741854
    Abstract: Feed supplements for poultry raised using a rapid growth regimen are disclosed herein. The supplements include D-ribose in an amount effective to improve the resistance to cardiomyopathy in the poultry. Methods for feeding poultry are also disclosed herein.
    Type: Grant
    Filed: February 19, 2010
    Date of Patent: June 3, 2014
    Assignee: Bioenergy, Inc.
    Inventors: John A. St. Cyr, Raj Khankari, Paul B. Addis
  • Publication number: 20120264701
    Abstract: Low doses of D-ribose raise the level of fitness and lower the perception of fatigue in baby boomers aged 45-65 who perceive themselves as fatigued. The doses range from 0.100 grams to 3.0 grams, bid, for a total of 0.200 to 6.0 grams daily. Objective measures of cardiopulmonary parameters confirm the improvement of fitness and questionnaires confirm that quality of life and mental states are improved with D-ribose administration.
    Type: Application
    Filed: April 11, 2012
    Publication date: October 18, 2012
    Applicant: Bioenergy, Inc.
    Inventors: John A. St. Cyr, Dean J. MacCarter
  • Publication number: 20120045426
    Abstract: The invention provides a formulation for treating stress and lessening fatigue. The formulation can be combined with water or another suitable liquid to provide a beverage for ease of administration. The formulation can include one or more of an energy compound, a vasodilator, a vasodilator adjuvant, and an antioxidant enhancer. In a typical formulation the energy compound is D-ribose or guanosine. The formulation can improve energy and alertness, and reduce the effects of stress and fatigue.
    Type: Application
    Filed: August 22, 2011
    Publication date: February 23, 2012
    Inventors: John A. St. Cyr, Dean J. MacCarter
  • Publication number: 20110021446
    Abstract: Feed supplements for poultry raised using a rapid growth regimen are disclosed herein. The supplements include D-ribose in an amount effective to improve the resistance to cardiomyopathy in the poultry. Methods for feeding poultry are also disclosed herein.
    Type: Application
    Filed: February 19, 2010
    Publication date: January 27, 2011
    Inventors: John A. St. Cyr, Raj Khankari, Paul B. Addis
  • Publication number: 20100189785
    Abstract: Low doses of D-ribose raise the level of fitness and lower the perception of fatigue in baby boomers aged 45-65 who perceive themselves as fatigued. The doses range from 0.100 grams to 3.0 grams, bid, for a total of 0.200 to 6.0 grams daily. Objective measures of cardiopulmonary parameters confirm the improvement of fitness and questionnaires confirm that quality of life and mental states are improved with D-ribose administration.
    Type: Application
    Filed: August 20, 2009
    Publication date: July 29, 2010
    Applicant: Bioenergy, Inc.
    Inventors: John A. St. Cyr, Dean J. MacCarter
  • Publication number: 20100099630
    Abstract: This invention is a method of improving the function of the pulmonary arm of the cardiac-pulmonary axis by the administration of a pharmaceutical or nutritional supplement to a patient in which the function of the pulmonary arm is suboptimal, but not as a sequella of dysfunction of the cardiac arm. The exemplar patient is one suffering from chronic obstructive pulmonary disease. The preferred pentose is D-ribose, to be administered chronically.
    Type: Application
    Filed: December 15, 2006
    Publication date: April 22, 2010
    Inventors: Dean J. MacCarter, John A. St. Cyr
  • Patent number: 7687468
    Abstract: D-Ribose, a buffer and an anticoagulant are added to whole blood or packed red cells to extend function in storage beyond 42 days. Methods are disclosed to rejuvenate suboptimally functional red cells. The methods are comprised of incubation of the cells at 37° C. for 10 to 60 minutes in the presence of D-ribose.
    Type: Grant
    Filed: May 14, 2003
    Date of Patent: March 30, 2010
    Assignee: Viacell, LLC.
    Inventors: John A. St. Cyr, Daniel G. Ericson, Clarence A. Johnson
  • Publication number: 20100055206
    Abstract: D-ribose is administered to patients suffering an acute myocardial infarction during first response care, in order to prevent cardiac compromise. In those patients able to ingest fluids, two to five grams of D-ribose is administered orally. In a patients unable to ingest fluids, or in a patient with and intravenous line, pyrogen-free D-ribose is administered intravenously at a rate of 50-300 mg/kg/hour.
    Type: Application
    Filed: April 2, 2009
    Publication date: March 4, 2010
    Inventors: John A. St. Cyr, David J. Perkowski
  • Publication number: 20100009924
    Abstract: The present invention relates to methods for supplementing the diet of subjects suffering from cardiovascular disease. D-Ribose is given long term alone or in combination with vasodilators in order to improve or maintain the diastolic or systolic function of the subjects.
    Type: Application
    Filed: June 26, 2009
    Publication date: January 14, 2010
    Applicant: Bioenergy, Inc.
    Inventors: Terri L. Butler, John St. Cyr, Clarence A. Johnson
  • Publication number: 20090286750
    Abstract: A method for treating a mammal suffering from a condition caused by aberrant neuron firing is disclosed herein. The method includes administering (e.g., orally administering) to the mammal (e.g., a human patient) in need thereof a therapeutically effective amount of a composition including D-ribose.
    Type: Application
    Filed: May 15, 2009
    Publication date: November 19, 2009
    Inventors: Robert V. Kasubick, John A. St. Cyr
  • Publication number: 20090232750
    Abstract: Compositions for inducing a natural tan of the skin is disclosed. The compositions contain D-ribose as the active ingredient plus a penetrant to deliver D-ribose to the basal cells and dermis of the skin. Compositions further containing emollients and emulsifiers are preferred.
    Type: Application
    Filed: March 13, 2008
    Publication date: September 17, 2009
    Inventor: John A. St. Cyr